Narayan Prabhu

2023

In 2023, Narayan Prabhu earned a total compensation of $1.2M as Chief Financial Officer at REVIVA PHARMACEUTICALS HOLDINGS, a 203% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$95,940
Option Awards$827,838
Salary$325,000
Total$1,248,778

Prabhu received $827.8K in option awards, accounting for 66% of the total pay in 2023.

Prabhu also received $95.9K in non-equity incentive plan and $325K in salary.

Rankings

In 2023, Narayan Prabhu's compensation ranked 942nd out of 2,770 executives tracked by ExecPay. In other words, Prabhu earned more than 66.0% of executives.

ClassificationRankingPercentile
All
942
out of 2,770
66th
Division
Manufacturing
562
out of 1,516
63rd
Major group
Chemicals And Allied Products
386
out of 855
55th
Industry group
Drugs
375
out of 821
54th
Industry
Pharmaceutical Preparations
254
out of 590
57th
Source: SEC filing on October 28, 2024.

Prabhu's colleagues

We found one more compensation record of an executive who worked with Narayan Prabhu at REVIVA PHARMACEUTICALS HOLDINGS in 2023.

2023

Laxminarayan Bhat

REVIVA PHARMACEUTICALS HOLDINGS

Chief Executive Officer

News

In-depth

You may also like